Search Results 1021-1030 of 17302 for Hypertriglyceridemia

  1. A Study of Patients Undergoing Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer to Evaluate Perioperative Circulating Tumor DNA as a Prognostic Biomarker - Mayo Clinic

    We will assess the relationship between major pathologic response (≤10% viable tumor remaining) and percent change in levels of ctDNA concentration before and ...

  2. Hepatopulmonary syndrome - Doctors and departments - Mayo Clinic

    This lung condition causes low oxygen levels and shortness of breath in people who have advanced liver disease.

  3. Endocrinology Update Endocrinology - Medical Professionals - Mayo Clinic

    Endocrine Update is a publication for physicians. It highlights trends in endocrinology-related procedures and research at Mayo Clinic.

  4. Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma - Mayo Clinic

    The purpose of this study is to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS ( ...

  5. EP study - Doctors & Departments - Mayo Clinic

    Areas of study have included: Leading a multicenter, multinational trial to compare drug therapy with cardiac ablation for people with heart rhythm disease.

  6. Mayo Clinic

    cc-woman-hiking-thumbnail ; About Mayo Clinic · About this Site · Contact Us ; Medical · AskMayoExpert · Clinical Trials ; Businesses · Executive Health Program.

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Ommaya at Biopsy - Mayo Clinic

    The purpose of this study is to determine the feasibility of placing Ommaya reservoirs at the time of biopsy to enable longitudinal CSF monitoring.

  9. Cirrhosis - Doctors and departments - Mayo Clinic

    Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers also are making ...

  10. Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment-Naïve Mantle Cell Lymphoma - Mayo Clinic

    Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment- ...